Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 753

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Prevalence, risk factors, and management of asthma in China: a national cross-sectional study

Open access
Huang, Kewu, Yang, Ting, Xu, Jianying, Yang, Lan, Zhao, Jianping, Zhang, Xiangyan, Bai, Chunxue, Kang, Jian, Ran, Pixin, Shen, Huahao, Wen, Fuqiang, Chen, Yahong, Sun, Tieying, Shan, Guangliang, Lin, Yingxiang, Xu, Guodong, Wu, Sinan, Wang, Chaolong, Wang, Ruiying, Shi, Zhihong, Xu, Yongjian, Ye, Xianwei, Song, Yuanlin, Wang, Qiuyue, Zhou, Yumin, Li, Wen, Ding, Liren, Wan, Chun, Yao, Wanzhen, Guo, Yanfei, Xiao, Fei, Lu, Yong, Peng, Xiaoxia, Zhang, Biao, Xiao, Dan, Wang, Zuomin, Chen, Zhengming, Bu, Xiaoning, Zhang, Hong, Zhang, Xiaolei, An, Li, Zhang, Shu, Zhu, Jianguo, Cao, Zhixin, Zhan, Qingyuan, Yang, Yuanhua, Liang, Lirong, Tong, Xunliang, Dai, Huaping, Cao, Bin, Wu, Tangchun, Chung, Kian Fan, He, Jiang, Wang, Chen·2019·The Lancet

Abstract

BACKGROUND Asthma is a common chronic airway disease worldwide. Despite its large population size, China has had no comprehensive study of the national prevalence, risk factors, and management of asthma. We therefore aimed to estimate the national prevalence of asthma in a representative sample of the Chinese population. METHODS A representative sample of 57 779 adults aged 20 years or older was recruited for the national cross-sectional China Pulmonary Health (CPH) study using a multi-stage stratified sampling method with parameters derived from the 2010 census. Ten Chinese provinces, representative of all socioeconomic settings, from six geographical regions were selected, and all assessments were done in local health centres. Exclusion criteria were temporary residence, inability to take a spirometry test, hospital treatment of cardiovascular conditions or tuberculosis, and pregnancy and breastfeeding. Asthma was determined on the basis of a self-reported history of diagnosis by a physician or by wheezing symptoms in the preceding 12 months. All participants were assessed with a standard asthma questionnaire and were classed as having or not having airflow limitation through pulmonary function tests before and after the use of a bronchodilator (400 μg of salbutamol). Risk factors for asthma were examined by multivariable-adjusted analyses done in all participants for whom data on the variables of interest were available. Disease management was assessed by the self-reported history of physician diagnosis, treatments, and hospital visits in people with asthma. FINDINGS Between June 22, 2012, and May 25, 2015, 57 779 participants were recruited into the CPH study. 50 991 (21 446 men and 29 545 women) completed the questionnaire survey and had reliable post-bronchodilator pulmonary function test results and were thus included in the final analysis. The overall prevalence of asthma in our sample was 4·2% (95% CI 3·1-5·6), representing 45·7 million Chinese adults. The prevalence of asthma with airflow limitation was 1·1% (0·9-1·4), representing 13·1 million adults. Cigarette smoking (odds ratio [OR] 1·89, 95% CI 1·26-2·84; p=0·004), allergic rhinitis (3·06, 2·26-4·15; p<0·0001), childhood pneumonia or bronchitis (2·43, 1·44-4·10; p=0·002), parental history of respiratory disease (1·44, 1·02-2·04; p=0·040), and low education attainment (p=0·045) were associated with prevalent asthma. In 2032 people with asthma, only 28·8% (95% CI 19·7-40·0) reported ever being diagnosed by a physician, 23·4% (13·9-36·6) had a previous pulmonary function test, and 5·6% (3·1-9·9) had been treated with inhaled corticosteroids. Furthermore, 15·5% (11·4-20·8) people with asthma reported at least one emergency room visit and 7·2% (4·9-10·5) at least one hospital admission due to exacerbation of respiratory symptoms within the preceding year. INTERPRETATION Asthma is prevalent but largely undiagnosed and undertreated in China. It is crucial to increase the awareness of asthma and disseminate standardised treatment in clinical settings to reduce the disease burden. FUNDING National Key R&D Program of China, Ministry of Science and Technology of China; the Special Research Foundation for Public Welfare of Health, Ministry of Health of China; the Chinese National Research Program for Key Issues in Air Pollution Control; and the National Natural Science Foundation of China.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(19)31147-x

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 753

Metadata

Authors
Huang, K., Yang, T., Xu, J., Yang, L., Zhao, J., Zhang, X., Bai, C., Kang, J., Ran, P., Shen, H., Wen, F., Chen, Y., Sun, T., Shan, G., Lin, Y., Xu, G., Wu, S., Wang, C., Wang, R., Shi, Z., Xu, Y., Ye, X., Song, Y., Wang, Q., Zhou, Y., Li, W., Ding, L., Wan, C., Yao, W., Guo, Y., Xiao, F., Lu, Y., Peng, X., Zhang, B., Xiao, D., Wang, Z., Chen, Z., Bu, X., Zhang, H., Zhang, X., An, L., Zhang, S., Zhu, J., Cao, Z., Zhan, Q., Yang, Y., Liang, L., Tong, X., Dai, H., Cao, B., Wu, T., Chung, K. F., He, J., & Wang, C.
Venue
The Lancet
Publisher
Elsevier BV
Published
2019-08
Volume
394
Issue
10196
Pages
407-418
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2949174534
Cited by
753
References
37
FWCI
41.43
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. https://app.cochat.ai/papers/10.1016/s0140-6736(19)31147-x
The paper
Huang, K., Yang, T., Xu, J., Yang, L., Zhao, J., Zhang, X., Bai, C., Kang, J., Ran, P., Shen, H., Wen, F., Chen, Y., Sun, T., Shan, G., Lin, Y., Xu, G., Wu, S., Wang, C., Wang, R., . . . Wang, C. (2019). Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. The Lancet. https://doi.org/10.1016/s0140-6736(19)31147-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.